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Abstract: Before immunocontraceptives can be considered safe to use on wildlife species, 
potential health risks should be assessed. Gonadotropin-releasing hormone (GnRH) 
immunocontraceptive has successfully reduced fertility of white-tailed deer (Odocoileus 
virginianus); however, associated deer physiology has rarely been examined. We conducted 
gross necropsy examinations, histology, and blood chemistry comparisons on euthanized 
deer previously vaccinated with immunogenic GnRH (n = 18 females and n = 4 males), or left 
as untreated controls (n = 7 females and n = 6 males). Granulomas were found at injection 
sites of most deer, even 3 years post-treatment. There were no signifi cant differences in ovary 
(F2,22 = 0.31, P = 0.73), or pituitary weights (F2,22 = 0.30, P = 0.75) between treatment groups. 
Ovaries from control females had signifi cantly more secondary follicles (F2,21 = 20.56, P ≤ 
0.001), but not Graafi an follicles (F2,22 = 2.22, P = 0.13). Immunized males had signifi cantly 
lower mean testes weights, a number of morphologic abnormalities, and varying degrees of 
aspermatogenesis with fewer mature spermatozoa. We do not recommend treating male deer 
with anti-GnRH immunocontraceptive vaccines.
Key words: deer–vehicle collision, GnRH, gonadotropin-releasing hormone, human–wildlife 
confl ict, immuno-contraception, Odocoileus virginianus, reproduction, white-tailed deer
Population densities of white-tailed deer 
(Odocoileus virginianus) in many suburban 
communities are reaching unprecedented lev-
els (Curtis and Richmond 1992, DeNicola et 
al. 2008) and continue to escalate throughout 
North America. In suburban sett ings, where 
deer densities are oft en highest, safety concerns 
and ethical issues have rendered population 
regulation via recreational hunting impractical 
(DeNicola and Williams 2008). Higher deer 
densities have caused increases in deer–vehicle 
collisions (DVCs; Hussain et al. 2007, Mastro et 
al. 2008), and there is no easy way to reduce the 
frequency of these collisions (Mastro et al. 2008, 
Ng et al. 2008). In response, eff orts to control 
growth of suburban deer herds with nonlethal 
methods, such as immunocontraception, have 
intensifi ed (Warren et al. 1995, Curtis et al. 1997, 
Cowan et al. 2003, Miller et al. 2008, Rutberg and 
Naugle 2008). However, recent modeling eff orts 
have shown that it will be very diffi  cult to at-
tain suffi  cient numbers of treated deer to have 
measurable reductions in open populations 
experiencing emigration and immigration 
(Merrill et al. 2006). Furthermore, community 
residents’ att itudes towards fertility control as 
a deer management option are not fi xed, and 
aft er stakeholders received additional informa-
tion concerning the eff ectiveness or humaneness 
of contraception, their perceived acceptance 
of this technique oft en declined (Lauber and 
Knuth 2004). Consequently, it is imperative that 
communities and wildlife management agen-
cies study all aspects of immunocontraception 
so that informed decisions can be made about 
applying these technologies for suburban 
wildlife management.
Fertility control as a tool in wildlife manage-
ment has been investigated for many years 
(Harder and Peterle 1974, Kennelly and 
Converse 1997) with variable results (Bomford 
1990, Turner et al. 1997, Warren et al. 1997). 
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However, success with eff ective fertility control 
of individual deer has been achieved by vaccin-
ating them with the immunocontraceptive 
antigens gonadotropin-releasing hormone 
(GnRH; Killian 1998, Miller et al. 2000a, Curtis 
et al. 2002, Killian et al. 2006) or porcine 
zona pellucida (PZP; Kirkpatrick et al. 1997, 
McShea et al. 1997, Miller et al. 2000b, Rutberg 
et al. 2004). While many researchers have 
documented successful fertility suppression, 
few investigators have considered the eff ects 
of immunocontraceptive vaccine treatment on 
deer physiology or histopathology (McShea 
et al. 1997, Killian et al. 2006). Kirkpatrick and 
Rutberg (2001) even stated that, “the absence of 
signifi cant health side eff ects” is an important 
characteristic of any contraceptive vaccine. 
Hence, in this study, we conducted detailed 
necropsies on anti-GnRH-immunized deer to 
document potential pathological impacts. 
Materials and methods
In accordance with an amendment approved 
by the Cornell University Institutional Animal 
Care and Use Committ ee (Protocol Number 
96-10-99), postmortem examinations were 
conducted on a sample of euthanized, free-
ranging, white-tailed deer (n = 18 females and 
4 males) that had been injected with an anti-
GnRH vaccine or left  as untreated controls (n = 
7 females and 6 males) during 1996–2000. The 
deer were included in a fertility control study 
contained within a 263-ha fenced, natural area 
at Seneca Army Depot near Romulus, New 
York (Curtis et al. 2002).
The immunocontraceptive vaccines used for 
the study were prepared by L. A. Miller (USDA/
APHIS/Wildlife Services’ National Wild-life 
Research Center). A 10-amino acid GnRH 
complex was made immunogenic by coupling 
it to the carrier keyhole limpet hemocyanin 
(KLH; Miller et al. 2000a). A glycine residue 
was added at the C-terminus of GnRH as a 
spacer, and cysteine residue was added to 
provide a coupling agent to maleimide on KLH. 
Maleimide-activated KLH was purchased from 
Pierce Chemical Company (Rockford, Ill.) and 
the C-terminal Cys-GnRH was coupled to the 
activated KLH following the manufacturer’s 
instructions. Both KLH-maleimide and the 
peptide were lyophilized and rehydrated in 
a 1:1 (weight:weight) ratio for coupling. Each 
1-ml dose of anti-GnRH vaccine contained 
0.5 mg of KLH-GnRH in 0.5 ml of phosphate-
buff ered saline (PBS) solution emulsifi ed with 
0.5 ml of Complete Freund’s Adjuvant (CFA) or 
Incomplete Freund’s Adjuvant (IFA). 
Treated deer had received a primary 
vaccination (KLH-GnRH + CFA) in the hip 
region with remotely delivered, self-injecting, 1-
ml darts (Pneu Dart Inc., Williamsport, Pa.). We 
administered the fi rst booster shot (KLH-GnRH 
+ IFA) 3 to 4 weeks later during September and 
October 1996 prior to the breeding season. A 
second booster dose (KLH-GnRH + IFA) was 
delivered by remote injection during September 
1997. No other booster treatments were given 
until 7 female deer were revaccinated in 2000 
(KLH-GnRH + IFA) to compare the eff ects of 
recent vaccination to deer previously treated 
3 years earlier. No males were revaccinated 
during 2000. 
With a permit from the New York State 
Department of Environmental Conservation 
(NYSDEC), we administered euthanasia of deer 
for necropsy in October 2000 using a single, 
lethal shot from a high-powered rifl e fi red 
either out of a blind or from a vehicle (Beaver et 
al. 2001). We collected blood samples via heart 
puncture immediately at the time of death, and 
we stored them in vials on ice for transport. 
Deer (n = 35) were quickly transported (usually 
within 1–2 hours aft er collection) to the Cornell 
University College of Veterinary Medicine 
(CUCVM), Necropsy Lab, and placed in a cooler 
at 4.4°C. Most necropsies were conducted the 
day the deer were collected. 
Blood chemistry analysis was performed by 
the CUCVM, Animal Health Diagnostic Center, 
on all of the collected deer. Anti-GnRH titer 
(1/titer x 1000) levels were determined via an 
enzyme-linked immunosorbent assay (ELISA), 
while progesterone and testosterone were de-
termined by radioimmunoassay (RIA; Miller et 
al. 2000a). These values were then compared to 
the deer’s histology and to its ovarian, testes, 
and pituitary weights.
Gross examinations included an accurate 
assessment of deer’s age by tooth wear 
(Severinghaus 1949), evaluation of bone marrow 
fat (Cheatum 1949), examination of injection 
sites, and documentation of any abnormalities. 
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Ovaries, testes, pituitary gland, internal iliac 
lymph node, popliteal lymph node, and thyroid 
glands were stripped of fat and connective 
tissue then weighed immediately (to the nearest 
mg). Morphologic analysis was performed on 
tissues fi xed in formalin, embedded in paraffi  n, 
sectioned to 7 microns, and stained with 
hemotoxylin and eosin, Masson’s Trichrome, or 
acid-fast stains. Each ovary, testis, and pituitary 
gland was halved before fi xation in formalin, 
and each half was embedded in paraffi  n. 
Multiple sections (but not step sections) were 
made of each surface to be examined with the 
previously mentioned stains, and if a suspected 
lesion was observed grossly, a section was also 
made through the lesion. 
The total number of secondary and Graafi an 
follicles were enumerated from 2 cross-sectional 
slices from each ovary from each deer. Any 
normal-appearing follicle with a corona radiata 
(a single layer of columnar cells anchoring 
the oocyte) or total follicular size >0.5 cm was 
classifi ed as a Graafi an follicle. Follicles with 
greater than 10% of their granulose cells (small 
cells that form the wall of an ovarian follicle) 
exhibiting cell death (apoptosis) were classifi ed 
as atretic ovarian follicles (degenerated prior 
to maturity). Apoptosis was characterized as 
granulose cells with dark, small consolidated 
(hyperchromatic) nuclei.
A single layer of cuboidal epithelium (surface) 
lined several large fl uid fi lled follicles. Because 
none of these follicles exceeded 1 cm in diameter, 
they were classifi ed as atretic Graafi an follicles; 
however, they could have been small follicular 
cysts. Also, some larger Graafi an follicles with 
diminished numbers of granulosa cells may 
have also been early follicular cysts. However, 
we found no advanced cyst to confi rm this. 
Results
Gross necropsy observations 
Blood chemistry. There was no signifi cant 
diff erence in any of 28 standard blood 
chemistry measures between control and anti-
GnRH-treated female (Table 1) or male deer 
(Table 2). Although there was some variation 
for selected blood parameters, these values 
fell within normal ranges, and patt erns were 
unremarkable. 
Body condition. On the basis of body weight, 
external visibility of individual rib bones, 
and subcutaneous fat observed during gross 
necropsy, most animals were judged in good 
to excellent condition and had a bone marrow 
fat score of >85%. Two exceptions were: (1) 
female no. 66, an anti-GnRH revaccinate in year 
2000, had poor body condition and was grossly 
underweight. She also had very poor teeth and 
had raised twins that summer. (2) Control female 
no. 323 had good body condition; however, her 
bone marrow fat score was <50%.
Injection sites. Injection sites for the year 2000 
revaccinates were compared to those for deer 
vaccinated in 1997 to evaluate current and 
former dart site lesions induced by Freund’s 
adjuvant. While abscesses were more evident 
and larger in recent revaccinates, granulomas 
could be found at the injection site of nearly all 
vaccinated deer.
Lung abscess. A 4x4-cm-circumscribed lung 
abscess, greenish in color, was noted during the 
necropsy of deer no. 25 (anti-GnRH-vaccinated 
female, year 2000). Tissue sections demonstrated 
this to be a giant cell granuloma containing acid 
fast bacilli similar to those found at the injection 
site.
Parasites. Three deer (nos. 13, 19, and 378) 
had liver cysts, most likely associated with the 
tapeworm Echinococcus granulosus, and 1 deer 
had an encysted parasite in skeletal muscle 
consistent with sarcosporidiosis (Sarcocystis 
spp.; no. 20). Each of these animals was in good 
to excellent body condition.
FIGURE 1. Buck treated with GnRH immunocontra-
ceptive vaccine, Romulus, New York, USA. Note 
malformed antlers covered in velvet during the rut.
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Multifocal lymphocytic infi ltrates. Focal infi l-
trates and nongiant cell granulomas were seen 
in kidney, skeletal muscle, and liver. These 
lesions were consistent with immunological 
action against migrating parasites in tissues.
Female deer
Neither combined ovarian weights (F2,22 
= 0.31, P = 0.73) nor pituitary weight (F2,22 = 
0.30, P = 0.75) diff ered signifi cantly between 
treatment groups and showed no correlation 
with antibody titer (Table 3). Mean anti-GnRH 
antibody titers were greater in the year 2000 
vaccinates than for control females (Table 3; t1 = 
2.31, P = 0.03). The average titer for female deer 
treated in 1997, including 2 of 8 deer that had no 
detectable titer, was not signifi cantly diff erent 
from control females (t1 = 0.13, P = 0.90).
The average total number of secondary 
follicles was less in both 1997 and year 2000 
vaccinates than for control females (F2,22 = 17.8, P 
≤ 0.001). The mean number of Graafi an follicles 
(F2,22 = 2.22, P = 0.13), and average total follicle 
count did not diff er between treatment groups 
(F2,22 = 1.60, P = 0.23).
Male deer
When collected in October 2000, most of 
the   male deer were in breeding condition 
with hardened antlers and swollen necks. 
Blood analysis confi rmed appreciable levels 
of testosterone in the bucks sampled. Average 
testosterone levels of the control males (312 ng 
[nanograms]/100 ml) were considerably higher 
Table 1. Means, standard errors, and t-test statistics for blood parameters of female white-tailed deer 
in control and anti-GnRH-treated groups at Seneca Army Depot, Romulus, New York, 2000.
Blood parameter Control group(±SE)
GnRH group
(±SE)
t-test results
Sodium (mEq/L) 141.00 ± 1.48 142.56 ± 1.04 t = 0.81 P = 0.43
Potassium (mEq/L) 11.77 ± 0.97 10.40 ± 0.84 t = 0.93 P = 0.36
Chloride (mEq/L) 103.50 ± 2.11 101.94 ± 0.92 t = 0.80 P = 0.43
Bicarbonate (mEq/L) 23.00 ± 2.21 24.06 ± 0.71 t = 0.61 P = 0.55
Cation-anion diff erence (mEq/L) 26.33 ± 4.18 27.53 ± 0.94 t = 0.41 P = 0.69
Urea nitrogen (mg/dL) 8.00 ± 1.51 13.82 ± 2.15 t = 1.54 P = 0.14
Creatinine (mg/dL) 1.27 ± 0.12 1.42 ± 0.06 t = 1.24 P = 0.23
Calcium (mg/dL) 9.75 ± 0.21 9.68 ± 0.17 t = 0.21 P = 0.83
Phosphate (mg/dL) 8.75 ± 1.11 8.16 ± 0.37 t = 0.66 P = 0.52
Magnesium (mg/dL) 2.55 ± 0.09 2.45 ± 0.07 t = 0.75 P = 0.46
Total protein (g/dL) 6.32 ± 0.36 6.75 ± 0.16 t = 1.29 P = 0.21
Albumin (g/dL) 3.13 ± 0.14 3.09 ±0.06 t = 0.34 P = 0.74
Globulin (g/dL) 3.18 ± 0.22 3.66 ± 0.14 t = 1.73 P = 0.10
Albumin:globulin ratio (A:G) 1.00 ± 0.04 0.87 ± 0.04 t = 1.90 P = 0.07
Glucose (mg/dL) 186.00 ± 82.08 155.06 ± 22.14 t = 0.52 P = 0.61
AST/PSTa (U/cL) 11.47 ± 5.29 10.85 ± 4.18 t = 0.08 P = 0.94
SDHb (U/L) 67.18 ± 13.56 73.42 ± 20.31 t = 0.18 P = 0.86
Alkaline phosphatase (U/L) 197.87 ± 132.52 81.71 ± 11.99 t = 1.49 P = 0.15
GGTc (U/L) 45.33 ± 2.80 51.88 ± 6.42 t = 0.59 P = 0.56
Total bilirubin (mg/dL) 0.17 ± 0.02 0.19 ± 0.04 t = 0.40 P = 0.69
Direct bilirubin (mg/dL) 0.05 ± 0.03 0.05 ± 0.02 t = 0.00 P = 0.99
Indirect bilirubin (mg/dL) 0.12 ± 0.03 0.14 ± 0.04 t = 0.44 P = 0.66
Creatine kinase (U/cL) 130.10 ± 66.44 159.41 ± 74.64 t = 0.22 P = 0.83
Iron (μg/dL) 155.67 ± 18.30 168.71 ± 10.98 t = 0.61 P = 0.55
TIBCd (μg/dL) 318.67 ± 28.24 353.94 ± 13.71 t = 1.24 P = 0.23
% saturation 48.50 ± 3.18 48.24 ± 3.01 t = 0.05 P = 0.96
Lipemia 32.50 ± 8.48 13.18 ± 2.67 t = 2.91 P = 0.01
Hemolysis 103.83 ± 34.68 115.59 ± 32.12 t = 0.20 P = 0.84
Note: A Bonferroni-corrected (n = 28 tests) alpha level of 0.05 is 0.002.
aaspartate aminotransferase; bsorbitol dehydrogenase; cgamma-glutamyltransferase; dtotal iron-
binding capacity
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than the vaccinated males (100 ng/100 ml) even 
3 years post-treatment. 
The mean combined testicular weight for 
anti-GnRH-treated male deer ( = 70.3) was 
signifi cantly lower (t1 = 3.56, P = 0.007) than 
for the control group ( = 130.5). Similarly, the 
average testes:pituitary index for anti-GnRH-
treated ( = 69.2) male deer was less (t1 = 2.52, 
P = 0.04) than for the control group ( = 130.0). 
However, there was no diff erence in pituitary 
weights (t1 = 0.30, P = 0.77) for anti-GnRH-
treated males ( = 1.0) and control ( = 1.0) 
bucks.
Morphologic alterations were observed in 
the testes of anti-GnRH-treated males (Table 
4). The pathologies included diff use lymph-
ocytic infi ltrate with associated seminifer-
ous tubule degeneration, segmental tubular 
aspermatogenesis (where large contiguous 
areas of the testes were seen with only sertoli-
Table 2. Means, standard errors, and t-test statistics for blood parameters of male white-tailed deer in 
control and anti-GnRH-treated groups, Seneca Army Depot, Romulus, New York, USA, 2000.
Blood parameter Control group(±SE)
 GnRH group
 (±SE)
t-test results
Sodium (mEq/L) 140.67 + 1.98   143.50 + 1.44 t = 1.04   P= 0.33
Potassium (mEq/L) 9.47 + 0.84   10.22 + 1.26 t = 0.52   P = 0.61
Chloride (mEq/L) 101.17 + 1.17   102.00 + 0.91 t = 0.51   P = 0.62
Bicarbonate (mEq/L) 25.00 + 1.46 27.00 + 0.41 t = 1.08   P = 0.31
Cation-anion diff erence (mEq/L) 23.83 + 1.74   25.00 +2.52 t = 0.40   P = 0.70
Urea nitrogen (mg/dL) 9.67 + 2.59   6.25 + 0.85 t = 1.03   P = 0.33
Creatinine (mg/dL) 1.57 + 0.13   1.52 + 0.20 t = 0.18   P = 0.86
Calcium (mg/dL) 9.98 + 0.20   10.18 + 0.44 t = 0.44   P = 0.67
Phosphate (mg/dL) 7.48 + 0.52 9.10 + 1.14 t = 1.46   P = 0.18
Magnesium (mg/dL) 2.30 + 0.08   2.30 + 0.16 t = 0.00   P = 0.99
Total protein (g/dL) 7.87 + 0.29   7.82+0.57 t = 0.07   P = 0.94
Albumin (g/dL) 3.43 + 0.10   3.18 + 0.10 t = 1.74   P = 0.12
Globulin (g/dL) 4.43 + 0.32   4.65 + 0.65 t = 0.33   P = 0.75
Albumin:Globulin ratio (A:G) 0.80 + 0.07   0.72 + 0.10
  
t = 0.64   P = 0.54
Glucose (mg/dL) 184.83 + 46.46   79.50 +123.89 t = 1.72   P = 0.12
AST/PSTa (U/cL) 5.17 + 2.16   4.96 + 2.35 t = 0.06   P = 0.95
SDHb (U/L) 39.30+ 7.48   40.58 + 12.41 t = 0.09   P = 0.93
Alkaline phosphatase (U/L) 61.17 + 16.86   67.25 + 8.78 t = 0.27   P = 0.79
GGTc (U/L) 57.00 + 6.35   51.50 + 4.56 t = 0.63   P = 0.55
Total bilirubin (mg/dL) 0.25 + 0.05   0.20 + 0.04 t = 0.65   P = 0.54
Direct bilirubin (mg/dL) 0.10 + 0.03   0.10 + 0.00 t = 0.00   P = 0.99
Indirect bilirubin (mg/dL) 0.15 + 0.03   0.10 + 0.04 t = 0.93   P = 0.38
Creatine kinase (U/cL) 53.24 + 25.89   49.26 + 32.48 t = 0.10   P = 0.93
Iron (μg/dL) 115.67 + 36.96   159.75 + 29.50 t = 0.85   P = 0.42
TIBCd (μg/dL) 336.00 + 16.59   417.75 + 56.64 t = 1.66   P = 0.14
% saturation 39.50 + 8.42   39.00 + 7.45 t = 0.04   P = 0.97
Lipemia 14.50 + 4.28   16.00 + 8.09 t = 0.18   P = 0.86
Hemolysis 41.50 + 16.71   46.75 + 19.17 t = 0.20   P = 0.84
Note: A Bonferroni-corrected (n = 28 tests) alpha level of 0.05 is 0.002.
aaspartate aminotransferase; bsorbitol dehydrogenase; cgamma-glutamyltransferase; dtotal iron 
binding capacity
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cell-lined tubules); subepithelial concretions in 
the collecting tubules, decreased cross-sectional 
diameter of seminiferous tubules, decreased 
cytoplasmic volume of Leydig cells, interstitial 
fi brosis, and total aspermatogenesis. Histology 
of testes from control males revealed none of 
these abnormalities. Among the treated males, 
one had only segmental aspermatogenesis 
with none of the associated pathologies. The 
remaining 3 males all had ≥2 of the abnormalities 
noted above. 
Male no. 31, had malformed (atypical) antlers 
still covered in velvet (Figure 1), exhibited total 
aspermatogenesis with small fi brotic testes, 
and vacant epididymi. This same male had 
no detectable anti-GnRH antibody titer, but 
also lacked any measurable blood testosterone 
level. The 3 other anti-GnRH vaccinated males 
did have some epididymal spermatozoa.
Discussion
Observations for both male and female 
deer
Lesions. A variety of infectious, parasitic, 
and noninfl ammatory lesions were observed 
in our study animals. Most noteworthy was 
the formation of granulomas at the injection 
site with all the characteristics of tuberculosis. 
These granulomas were characterized by the 
presence of a necrotic core surrounded by mixed 
infl ammatory cells and fi brous connective 
tissue. All granulomas had Langerhans giant 
cells typical of a tuberculosis condition. Like-
wise, giant cell infl ammation was seen in the 
regional (popliteal) and deep (intral iliac) lymph 
nodes draining these sites. Acid fast bacilli were 
documented in these giant cells. 
These injection site lesions and reactions, 
including the production of multi-nucleated 
giant cells associated with the presence of 
Mycobacteria in the adjuvant in other species 
vaccinated with CFA have been previously 
described (Stills and Bailey 1991, Kleinman 
et al. 1993, Munson et al. 2005, Stills 2005). In 
other studies, remote lesions comparable in 
composition to the Freund’s injection sites had 
also been documented in lungs and other organs 
(Rigdon and Schadewald 1972, Broderson 1989, 
Kleinman et al. 1993, Malaga et al. 2004).
When evaluating the safety of immunocontra-
ceptive vaccines, potential complications 
associated with treatment should be considered. 
Killian et al. (2006) reported that pulmonary 
disease was the most common cause of death in 
their captive deer herd and that males treated 
with anti-GnRH vaccine had signifi cantly 
higher mortality than did control deer. Microbes 
associated with pneumonia were endemic 
in their captive herd and anti-GnRH-treated 
bucks appeared less resistant to infection. 
Table 3.  Mean left  and right ovary weights (milligrams), pituitary gland weights, anti-GnRH anti-
body titers, and follicle counts for control does vaccinated during 1977 or 2000 with anti-GnRH at 
Seneca Army Depot, Romulus, New York, 2000. 
   Control
   does
Anti-GnRH does
1997  2000 F df P
    n = 7 n = 11  n = 7
Left  ovary    502.4 421.2  505.4 0.71 2,22 0.50
Right ovary    497.1 446.4  475.2 0.15 2,21 0.86
Pituitary gland    788.1 729.0  733.9 0.30 2,22 0.75
Titer (1/titer x 1,000)     0.0 1,700  31,100 3.37 2,18 0.06
Secondary follicles
   Normal     8.1 3.4  5.9 3.38 2,22 0.05
   Atretic    10.3 3.1   3.3 11.2 2,22 0.0004
   % Atretic    55.1 55.3   38.5
Graafi an follicles
   Normal     0.6 3.2   5.7 2.65 2,22 0.09
   Atretic     1.6 4.4   2.1 2.34 2,22 0.12
   % Atretic     84.2 42.3   32.2
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Likewise, Miller et al. (2000b) reported that 3 
female deer died of complications resulting 
from pneumonia during a study of porcine 
zona pellucida (PZP) immunocontraceptive 
with Freund’s adjuvant. It was unclear if there 
was an association between the pneumonia 
cases and treatment with Freund’s adjuvant. 
Bearing in mind the warning by Billiau and 
Matt hys (2001) that too few studies consider the 
biological eff ects of using CFA when evaluating 
experimental vaccines, we feel that future 
researchers should examine the possibility that 
injections with CFA could predispose deer to 
pneumonia. 
Hypothalamic-pituitary response. Normally 
GnRH released from the hypothalamus circu-
lates into the anterior pituitary gland where 
it activates production of follicle stimulating 
hormone (FSH) and luteinizing hormone 
(LH) by gonadotrophs. Antibodies to GnRH 
interacted with neurons secreting GnRH from 
the hypothalamus at terminals within the 
median eminence. These GnRH release points 
are accessible because they are not within the 
blood-brain barrier that otherwise protects the 
hypothalamus from circulating antibodies. One 
study demonstrated degeneration of the neuron 
cell bodies (perikarya) and a sharp decrease 
of the GnRH immunochemical reactivity in 
the terminals within the median eminence of 
hyperimmunized hogs (sus scrofa; Molenaar 
et al. 1993). With hymotoxylin and eosin stain 
on fi xed pituitary gland tissue, gonadotrophs 
appear as large cells with secretory granules 
of moderate and variable size. Cells with litt le 
or no cytoplasmic staining (chromophobes) 
are likely degranulated chromophilic cells. 
Thus, we classifi ed large granule-bearing cells 
as gonadotrophs in this study, and found large 
variation in their numbers among females in 
each treatment group. A more precise staining 
method would involve immunoperoxidase 
staining with anti-LH/FSH. This would allow 
simultaneous quantifi cation of cell numbers 
and the relative intensity of intracytoplasmic 
LH/FSH stores.
Female deer 
Titers in 5 of the 7 deer revaccinated in 2000, 
and 6 of the 8 deer last vaccinated in 1997 
were well below the level of 64,000 to 128,000 
identifi ed in deer with successful contraception, 
or the 16,000 to 32,000 level for contragestation 
(Miller et al. 2000a). Because the revaccinates 
in 2000 were retreated <4 weeks prior to 
collection, it is possible that the immune 
response was incomplete and that a peak 
anti-GnRH titer would be greater. Lower anti-
GnRH titer in females vaccinated in 1997 than 
those vaccinated in the 2000 treatment group 
validates the assumption that, if not boosted, 
the anti-GnRH vaccine treatment is reversible 
for most deer. There were no identifi able health 
concerns associated with anti-GnRH treatment 
for female deer.
Male deer
Litt le has been reported about the eff ects of 
anti-GnRH vaccination on the reproductive 
physiology of male deer. Miller et al. (2000a) 
injected 4 male deer with the anti-GnRH vaccine, 
and testes size observed for treated bucks 
was <50% testes size in control bucks. Killian 
et al. (2006) also observed similar physical 
diff erences in testicular size and qualifi ed those 
observations reporting histological changes 
in the testes “which resembled the testes of 
males during the non-breeding season.” They 
further noted that the Leydig cells, which 
produce testosterone, appeared inactive in 
anti-GnRH treated males. Similar testicular 
pathologies have also been documented in 
research conducted on hogs (Molenaar et al. 
1993, Meloen et al. 1994). 
It is clear from testes weights and histology 
that sperm production was reduced, even 3 
years aft er the last anti-GnRH vaccination. 
The signifi cantly lower average weight of 
testes in this study correlated with a number 
of persistent morphologic abnormalities and 
decreased (qualitative assessment) spermatozoa 
in epididymi. Observing these eff ects 3 years 
aft er vaccination suggested that anti-GnRH 
vaccination early in the adult lives of deer may 
be sustained over several years. Similarly, in 
a study on 3- to 4-year-old sheep vaccinated 
with anti-GnRH antigen as neonates, Clarke et 
al. (1998) reported that in these study animals 
males had small gonads and females had no 
large follicles or corpora lutea, and titers had 
dropped to undetectable levels. 
Immunized bucks had reduced cross-sec-
tional diameter of seminiferious tubules and 
varying degrees of aspermatogenesis, including 
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buck no. 31 with total aspermatogenesis that 
was vaccinated at 3.5 years of age. This latt er 
animal had no detectable anti-GnRH titer, 
suggesting a possible permanent alteration 
in the hypothalamic-pituitary-testes axis. The 
other 3 anti-GnRH treated bucks had normal 
outward physical traits and detectible mature 
spermatozoa, although the latt er were fewer 
than normal. While it was not possible to 
assess their actual fertility from this study, this 
evidence suggests that anti-GnRH contraception 
is reversible; however, some portion of treated 
males may become permanently sterilized. 
Variations in the residual immune response 
and the extent of physiological, morphological, 
or pathological diff erences among the treated 
deer are thought to be due to genetic diff erences 
among individual animals (Miller et al. 2000a). 
In fact, substantial research has been conducted 
using anti-GnRH vaccines to chemically castrate 
hogs as an alternative to surgical castration 
typically used to control boar taint, with con-
siderable variations in effi  cacy documented 
(Molenaar et al. 1993, 1994; Oonk et al. 1995, 
1998). 
Management implications
Many factors aff ect the success and potential 
pathology associated with an immunocontra-
ceptive vaccine, including formulation of the 
immunogen, concentration of the immunogen, 
adjuvant used, and species treated. Therefore, 
before judgments can be made concerning the 
eff ectiveness and health risks associated with a 
given vaccine for a particular species, adequate 
evaluation must be conducted.
Curtis et al. (2002) demonstrated that vac-
cinating free-ranging female white-tailed deer 
with anti-GnRH immunocontraceptive vaccines 
can be eff ective at reducing fawn production. 
We further evaluated anti-GnRH vaccinated 
deer and identifi ed no detrimental, morphologic 
eff ects that could jeopardize the normal health 
of vaccinated females. Vaccinating female 
deer with anti-GnRH vaccines eliminates the 
potential problems associated with repeated 
estrous cycl-ing commonly observed in deer 
treated with PZP  immunocontraceptive vac-
cines (McShea et al. 1997, Miller et al. 2000b, 
Kirkpatrick and Rutberg 2001). Baker et al. 
(2004) studying leuprolide, a GnRH agonist, 
which would cause similar eff ects as the anti-
GnRH immunocontraceptive vaccine used in 
this study, also reported no signifi cant adverse 
health impacts to female deer resulting from 
the reduced systemic GnRH. Furthermore, 
if GnRH could be administered to newborn 
female fawns, as Clarke et al. (1998) were able 
to do with neonatal lambs, considerable long-
term effi  cacy could be achieved. 
Morphologically, anti-GnRH-treated males 
essentially became neutered and exhibited be-
havioral and physiological traits consistent with 
castrated males (Pooler 2001, Killian et al. 2006). 
Antlers on treated males did not harden or shed 
velvet and became atrophied (Killian 1998, 
Miller et al. 2000a, Curtis et al. 2002, Killian et 
al. 2006). Such antlers are spindly, atypical, and 
possibly pose a health risk to deer from frost bite 
when they freeze and break off  during winter. 
Treated male deer also could develop adverse 
health eff ects including increased risk for 
pneumonia. Killian et al. (2006) recommended 
that anti-GnRH vaccines should not be used on 
male deer due to these concerns. Our results 
were consistent with these previous studies, 
and we also do not recommend treating male 
deer with anti-GnRH vaccines. 
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